China NT Pharma Group Co., Ltd. (HK:1011) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
China NT Pharma Group has announced a delay in the distribution of a crucial circular related to a connected transaction involving loan capitalization and share subscription, originally expected by December 2024. The company has applied for an extension until January 2025 to finalize the circular’s contents, which are essential for proceeding with the transaction. The completion of this transaction hinges on the approval of a Whitewash Waiver by the Executive and the company’s Independent Shareholders.
For further insights into HK:1011 stock, check out TipRanks’ Stock Analysis page.